Not finding it? Sign in to also search OpenAlex live.
-
Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
Steffen Koschmieder, Susanne Isfort, Florian Heinrich Heidel, Andreas Hochhaus, Heiko Becker, Philipp Jakob Jost, +19 more
3citations -
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review2022 Journal of Psychopharmacology review Psychology Psychedelics and Drug Studies Open access cited by 2 patents
Joost J. Breeksema, Bouwe Kuin, Jeanine Kamphuis, Wim van den Brink, Eric H. G. J. M. Vermetten, Robert A. Schoevers
179citations -
Management of endocrine disease: update on the management of pituitary apoplexy2026 European Journal of Endocrinology review Medicine Pituitary Gland Disorders and Treatments Open access
Betina Biagetti, Pedro Marques, Georgia Ntali, Georgios Tsermoulas, Niki Karavitaki, Silvana Sarria‐Estrada, +1 more
5citations -
Proof of pharmacology of Org 48775‐0, a p38 MAP kinase inhibitor, in healthy volunteers2020 British Journal of Clinical Pharmacology article Biochemistry, Genetics and Molecular Biology Protein Tyrosine Phosphatases
Matthijs Moerland, Andrea J. Kales, Karen Broekhuizen, U. K. Nässander, Rob L. H. Nelissen, Marieke L. de Kam, +2 more
2citations -
MO555ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) MEASURES FOR PAEDIATRIC PATIENTS WITH ANAEMIA OF CHRONIC KIDNEY DISEASE (CKD)2021 Nephrology Dialysis Transplantation article Medicine Erythropoietin and Anemia Treatment Open access
Antonia Morga, Ana Filipa Alexandre, Patricia E. Koochaki, C. Desvignes-Gleizes
1citations -
Safety and Tolerability of an Ad26.RSV.preF-based Vaccine in a Phase 2b Study in Older Adults2021 Innovation in Aging conference-abstract Medicine Respiratory viral infections research Open access
Ann Regina Falsey, Efi Gymnopoulou, Stephan Bart, John E. Ervin, Els De Paepe, Esther Heijnen, +1 more
0citations -
monarch-initiative/mondo: v2026-02-032026 Zenodo (CERN European Organization for Nuclear Research) software Biochemistry, Genetics and Molecular Biology Biomedical Text Mining and Ontologies Open access
Nicole Vasilevsky, Chris J Mungall, Nicolas Matentzoglu, Sabrina Toro, Trish Whetzel, MeeSiing Ngu, +21 more
0citations -
CHARACTERIZATION OF BACTEREMIC AND NON-BACTEREMIC SYNDROMES OF INVASIVE ESCHERICHIA COLI DISEASE AMONG HOSPITALIZED ADULTS AGED ≥60 YEARS: FINDINGS FROM A PROSPECTIVE, MULTINATIONAL, OBSERVATIONAL STUDY (EXPECT-2)2023 International Journal of Infectious Diseases article Veterinary Brucella: diagnosis, epidemiology, treatment Open access
Joachim Doua, Jesús Rodríguez‐Baño, Christine Vallejo, P. Puranam, Oscar T. Go, Jeroen Geurtsen, +12 more
0citations -
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria2021 New England Journal of Medicine article Immunology and Microbiology Complement system in diseases Open access cited by 1 patent
Peter Hillmen, Jeff Szer, Ilene Ceil Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, +11 more
407citations -
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access cited by 1 patent
Philip J. Mease, Atul A. Deodhar, Désirée M F M van der Heijde, Frank Behrens, Alan Kivitz, Jeffrey Neal, +4 more
215citations -
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial2020 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 7 patents
Andrew John Pollard, Odile Launay, Jean‐Daniel Lelièvre, Christine Lacabaratz, Sophie Grande, Neil H. Goldstein, +84 more
173citations -
Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy2020 Kidney International Reports article Medicine Renal Diseases and Glomerulopathies Open access cited by 18 patents
Richard A. Lafayette, Brad H. Rovin, Heather N. Reich, James Alan Tumlin, Jürgen Floege, Jonathan Barratt
161citations -
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials2023 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Atul A. Deodhar, Xenofon Baraliakos, Matthew Brown, Hiroaki Dobashi, Maxime Dougados, +18 more
120citations -
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)
Botond Szabolcs Csiky, Michael Schömig, Ciro Esposito, Jonathan Barratt, Udaya Valluri, Władysław Sułowicz
111citations